Do we know to what extent antibody durability accounts for patient outcomes, compared with shades of immunological memory, for various strains of SARS-CoV-2? It's a shame such important work hasn't been widely and thoroughy conducted (as far as I can see from the outside googling in), but hope to understand better in the future.